The novel transferrin E592A variant impairs the diagnostics of congenital disorders of glycosylation

Conventional diagnostic methods for CDG are hindered by the novel transferrin E592A. Neuraminidase treatment followed by IEF and ESI-TOF MS can identify the mutation. The mutation appears to be functionally normal.